Cronos Group Inc
$ 3.10
0.98%
07 Aug - close price
- Market Cap 1,142,080,000 USD
- Current Price $ 3.10
- High / Low $ 3.17 / 3.06
- Stock P/E 16.32
- Book Value 2.85
- EPS 0.19
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE 0.07 %
- 52 Week High 3.43
- 52 Week Low 2.28
About
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
Analyst Target Price
$2.55
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-06 | 2026-05-11 | 2026-02-26 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-02-27 | 2024-11-12 | 2024-08-08 | 2024-05-09 | 2024-02-29 | 2023-11-08 |
| Reported EPS | 0.03 | 0.05 | -0.0047 | 0.1 | -0.1 | 0.03 | 0.1587 | 0.03 | -0.02 | -0.01 | -0.05 | -0.02 |
| Estimated EPS | 0.01 | 0.01 | 0.01 | 0.02 | -0.02 | -0.0035 | -0.0093 | -0.01 | -0.07 | -0.01 | -0.01 | -0.04 |
| Surprise | 0.02 | 0.04 | -0.0147 | 0.08 | -0.08 | 0.0335 | 0.168 | 0.04 | 0.05 | 0 | -0.04 | 0.02 |
| Surprise Percentage | 200% | 400% | -147% | 400% | -400% | 957.1429% | 1806.4516% | 400% | 71.4286% | 0% | -400% | 50% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CRON
2026-08-07 21:40:41
Cronos Group Inc. director Murray R. Garnick was granted 48,859.93 Deferred Share Units on August 6, 2026. These units are cash-settled, meaning upon redemption, Garnick will receive a cash payment equal to the fair market value of Cronos common shares. Following this grant, his total holdings of Deferred Share Units amount to 179,594.40, which will be mandatorily redeemed in cash after he ceases to be a director.
2026-08-07 21:40:41
Cronos Group Inc. director Jason Marc Adler was granted 48,859.93 Deferred Share Units, bringing his total holdings to 362,742.22 units. These units are cash-settled based on the fair market value of Cronos Group common shares upon redemption, which occurs after he ceases to be a director. The transaction, filed as a Form 4, is neutral in sentiment and involves no immediate cash cost to the director.
2026-08-07 21:40:41
Cronos Group Inc. director James Daniel Rudyk was granted 48,859.9300 Deferred Share Units (DSUs) on August 6, 2026, bringing his total direct holdings to 362,742.2200 DSUs. These DSUs entitle him to a lump-sum cash payment equal to the fair market value of a Cronos common share upon redemption, which occurs mandatorily on the first trading day after he ceases to be a director. This transaction is classified as neutral in terms of filing impact and sentiment, as DSUs are cash-settled rights rather than direct share purchases or sales.
2026-08-07 12:40:45
This article identifies undervalued TSX stocks based on discounted cash flow, highlighting Cronos Group, Timbercreek Financial, and Lumine Group. It provides an overview of each company's operations, estimated discount to fair value, and recent financial performance, suggesting potential opportunities for investors in the Canadian market.
2026-08-07 06:40:45
Cronos Group (TSX:CRON) reported a strong second quarter in 2026, swinging back to a net profit of US$32.09 million and beating revenue and earnings expectations. The company achieved net income of US$45.84 million for the first half of 2026, with basic earnings per share improving significantly. This return to profitability and an expanded share repurchase program are key factors reshaping the investment narrative for Cronos Group.
2026-08-06 23:40:45
Cronos Group reported a strong Q2 2026, beating Wall Street estimates with record revenue and profit, which caused its shares to jump by 13.2%. The cannabis company saw significant growth in Canada, Israel, and other international markets, driven by higher selling prices, an improved product mix, and better growing conditions. Management is optimistic about continued growth, including efficiency gains at its GrowCo facility and the upcoming acquisition of CanAdelaar in the Netherlands.
